Cancer diagnostics company Biolidics is to raise S$3.13m (US$2.2m) from a share placement exercise. It intends to issue 17.9 million shares at S$0.175 per share. This is a 7.3% discount…
Cancer diagnostics company Biolidics is to raise S$3.13m (US$2.2m) from a share placement exercise. It intends to issue 17.9 million shares at S$0.175 per share. This is a 7.3% discount…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


